BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22896752)

  • 1. The genealogy of SEREX.
    Pfreundschuh M
    Cancer Immun; 2012; 12():7. PubMed ID: 22896752
    [No Abstract]   [Full Text] [Related]  

  • 2. The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens.
    Chen YT
    Cancer Immun; 2012; 12():8. PubMed ID: 22896753
    [No Abstract]   [Full Text] [Related]  

  • 3. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
    Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
    Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies.
    Ritter G
    Cancer Immun; 2012; 12():9. PubMed ID: 22896754
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploitation of the B cell repertoire for the identification of human tumor antigens.
    Pfreundschuh M
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting targeted therapies.
    Shingler W; Harrop R
    Immunotherapy; 2010 Nov; 2(6):745-8. PubMed ID: 21091104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor vaccination using monoclonal antibodies].
    Veelken H
    Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
    Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
    Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity.
    Shiku H; Takahashi T
    Cancer Immun; 2012; 12():3. PubMed ID: 22896748
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
    Jäger D
    Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines.
    Jäger E; Knuth A
    Cancer Immun; 2012; 12():6. PubMed ID: 22896751
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer vaccines.
    Dalgleish AG
    Br J Cancer; 2000 May; 82(10):1619-24. PubMed ID: 10817493
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
    Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
    Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
    Hanafusa T; Mohamed AE; Kitaoka K; Ohue Y; Nakayama E; Ono T
    Cancer Lett; 2011 Feb; 301(1):57-62. PubMed ID: 21094583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
    Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
    Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical promise of tumour immunology.
    Scott AM; Cebon J
    Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of tumor-associated autoantigens with SEREX.
    Türeci O; Usener D; Schneider S; Sahin U
    Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.